Marcia S Pereira
Overview
Explore the profile of Marcia S Pereira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigues C, Gaifem J, Pereira M, Alves M, Silva M, Padrao N, et al.
Gut Microbes
. 2025 Feb;
17(1):2461210.
PMID: 39918275
The perturbation of the symbiotic relationship between microbes and intestinal immune system contributes to gut inflammation and Inflammatory Bowel Disease (IBD) development. The host mucosa glycans (glycocalyx) creates a major...
2.
Gronke K, Nguyen M, Fuhrmann H, Santamaria de Souza N, Schumacher J, Pereira M, et al.
Sci Transl Med
. 2025 Feb;
17(784):eadj6294.
PMID: 39908347
Chronic autoimmune diseases often lead to long-term sequelae and require lifelong immunosuppression because of an incomplete understanding of the triggers and drivers in genetically predisposed patients. Gut bacteria that escape...
3.
Pereira M, Kriegel M
Cell
. 2023 Apr;
186(9):1821-1823.
PMID: 37116468
Variability in the efficacy of immune checkpoint inhibitors in cancer patients is associated with the human gut microbiota. However, detailed mechanisms are unclear. In this issue of Cell, Bender et ...
4.
Pereira M, Kriegel M
Curr Opin Immunol
. 2022 Nov;
80:102265.
PMID: 36444784
Autoimmune diseases are complex, multifactorial diseases with a polygenic trait and diverse environmental factors that contribute to triggering and exacerbating each disorder. The human microbiome is increasingly implicated in the...
5.
Dehner C, Ruff W, Greiling T, Pereira M, Redanz S, McNiff J, et al.
JID Innov
. 2022 Feb;
2(2):100084.
PMID: 35199089
Cutaneous T-cell lymphoma (CTCL) is a life-debilitating malignancy of lymphocytes homing to the skin. Although CTCL is thought to arise from a combination of genetic, epigenetic, and environmental factors, specific...
6.
Pereira M, Redanz S, Kriegel M
J Invest Dermatol
. 2022 Jan;
142(3 Pt B):834-840.
PMID: 35027173
The skin microbiota is thought to possibly contribute to the pathogenesis of skin autoimmune diseases. The gut microbiota affects systemically the development and function of the immune system, thereby potentially...
7.
Pereira M, Duraes C, Catarino T, Costa J, Cleynen I, Novokmet M, et al.
Clin Transl Gastroenterol
. 2020 May;
11(4):e00166.
PMID: 32352685
Objectives: The impact of genetic variants (single nucleotide polymorphisms [SNPs]) in the clinical heterogeneity of ulcerative colitis (UC) remains unclear. We showed that patients with UC exhibit a deficiency in...
8.
Pereira M, Alves I, Vicente M, Campar A, C Silva M, Padrao N, et al.
Front Immunol
. 2018 Dec;
9:2754.
PMID: 30538706
The immune system is highly controlled and fine-tuned by glycosylation, through the addition of a diversity of carbohydrates structures (glycans) to virtually all immune cell receptors. Despite a relative backlog...
9.
Pereira M, Maia L, Azevedo L, Campos S, Carvalho S, M Dias A, et al.
J Crohns Colitis
. 2018 Sep;
13(1):39-49.
PMID: 30239648
Background And Aims: There is a clinical need to identify biomarkers able to select patients who are most likely to develop aggressive/complicated disease, for early selection for appropriate therapy. Changes...
10.
M Dias A, Pereira M, Padrao N, Alves I, Marcos-Pinto R, Lago P, et al.
Cell Immunol
. 2018 Jul;
333:9-18.
PMID: 30049413
The diversity of glycans expression within a cell or an organism is enormous and the amount of relevant biological information that each glycan structure encodes is far from being clarified....